Drug dispenser giant CVS Caremark (NYSE:CVS) closed out its year by reporting impressive growth in its pharmacy services business. This growth has taken close to five years to achieve, and while the top line trends look encouraging, the total profit growth outlook looks more challenging. Combined with a significant recent stock run, the investment appeal of the stock doesn't currently appear overly healthy.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Full-Year Recap
Sales advanced 11.8% to $107.1 billion. The leading contributor was pharmacy services, or the Caremark pharmacy benefit management (PBM) arm that competes with pure play rivals including Medco Health Solutions (NYSE:MHS) and Express Scripts (Nasdaq:ESRX), which are actually planning to merge and create the dominant PBM player.

Health insurers, including UnitedHealth Group (NYSE:UNH), also operate their own PBM businesses. The PBM segment for CVS posted an impressive 24.9% annual growth. The CVS retail pharmacy, which competes with Rite Aid (NYSE:RAD), reported respectable growth of 3.9% as same-store sales improved 2.3%. Each unit accounted for roughly half of total sales.

The retail pharmacy business is much more profitable and brought in $4.5 billion in profits for the year. In contrast, the PBM side brought in $2.4 in operating income. Total operating income was $6.1 billion. Pre-tax income rose a modest 2.6% to $5.7 billion. Higher income tax expense meant net income rose less than 2% to $3.5 billion. Share buybacks boosted the bottom line a bit more to 3.2% as earnings per diluted share reached $2.57. Free cash flow came in at approximately $2.91 per diluted share. (To know more about income statements, read Understanding The Income Statement.)

Outlook
For the coming year, CVS expects to report earnings in a range of $2.96 to $3.06. Analysts currently project sales growth of nearly 12% and total sales of almost $120 billion. The company said to expect strong free cash flow production between $4.6 billion and $4.9 billion, or roughly $3.41 and $3.64 per diluted share.

The Bottom Line
CVS shares are bumping up against their highs for the year and currently trade at a forward P/E of about 12. The forward free cash flow multiple is slightly more reasonable at less than 12, but both multiples suggest that much of CVS Caremark's future growth is already discounted in the share price. The PBM business is finally seeing some nice growth trends, which are the first since CVS merged with Caremark in 2007.

However, it looks to be gaining new business with aggressive pricing that could make total company profit growth more difficult to sustain over the long haul. Retailing trends are more steady, but it will be hard for CVS to grow its store count aggressively going forward. (For additional reading, check out 5 Must-Have Metrics For Value Investors.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  3. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  4. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  5. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  6. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  7. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  8. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  9. Mutual Funds & ETFs

    3 Vanguard Equity Fund Underperformers

    Discover three funds from Vanguard Group that consistently underperform their indexes. Learn how consistent most Vanguard low-fee funds are at matching their indexes.
  10. Investing News

    Alphabet Earnings Beat Expectations (GOOGL, AAPL)

    Alphabet's earnings crush analysts' expectations; now bigger than Apple?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center